United States · FDA National Drug Code directory
NAPROXEN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43063-920_415db902-541e-accc-e063-6394a90a54e5
- Product NDC
- 43063-920
- Form
- TABLET
- Composition / generic term
- NAPROXEN
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160706
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 TABLET in 1 BOTTLE, PLASTIC (43063-920-04) · 43063-920-04
- 6 TABLET in 1 BOTTLE, PLASTIC (43063-920-06) · 43063-920-06
- 14 TABLET in 1 BOTTLE, PLASTIC (43063-920-14) · 43063-920-14
- 15 TABLET in 1 BOTTLE, PLASTIC (43063-920-15) · 43063-920-15
- 20 TABLET in 1 BOTTLE, PLASTIC (43063-920-20) · 43063-920-20
- 28 TABLET in 1 BOTTLE, PLASTIC (43063-920-28) · 43063-920-28
- 30 TABLET in 1 BOTTLE, PLASTIC (43063-920-30) · 43063-920-30
- 60 TABLET in 1 BOTTLE, PLASTIC (43063-920-60) · 43063-920-60
- 90 TABLET in 1 BOTTLE, PLASTIC (43063-920-90) · 43063-920-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →